An interventional study of Placebo and Fluconazole 150 mg in Cardiovascular, sponsored by Université de Sherbrooke. Recruiting at 1 site in Canada. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-13.
Sponsored by Université de Sherbrooke · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 73 studies in Sedentary Behavior with a site in Canada — 18 open to participants now, 19 under way, none of them phase 3. Sedentary Behavior · Canada.
Among the 73 studies in Sedentary Behavior with a site in Canada, this one is the 43rd largest by planned enrollment of the 69 interventional ones that give a count, is one of 5 that started in 2025, is one of 67 with no phase, reaches primary completion later than 10 of the 18 other live ones, and was the 71st registered.
1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.
Browse Sedentary Behavior studies →18 of the 73 studies in Sedentary Behavior with a site in Canada are open now. Recruiting first, the newest first:
University of British Columbia · Sites in Canada
Ages 50+
University of Alberta · Sites in Canada
Ages 50+
The Royal Ottawa Mental Health Centre · Sites in Canada
Ages 18–75
Nova Scotia Health Authority · Sites in Canada
Ages 65+
University of British Columbia · Sites in Canada
Ages 50+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
73 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 5 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 60 across 1,077 interventional studies indexed under Sedentary Behavior.
Median enrollment 50 across the 69 interventional studies, 336 across the 4 observational. Of the 46 that completed or were terminated, 4 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 73 has an industry lead sponsor. The 10 most frequent:
Université de Sherbrooke is the lead sponsor of 298 studies on the registry; 67 are open to participants now.
Université de Sherbrooke has 1 study filed under Sedentary Behavior — fewer than ten, so there is no comparison to draw.
5 of the studies in Sedentary Behavior with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07396857Université de SherbrookeThe Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting | 2026-12-15 |
| NCT06773949The Royal Ottawa Mental Health CentreFeasibility Trial of Exercise as a Priming Strategy for rTMS Treatment in Difficult-to-Treat Depression | 2027-01-31 |
| NCT06252259University of British ColumbiaEvaluating Implementation and Impact of the Adapted Choose to Move (CTM) Program | 2027-03 |
| NCT06446414University of British ColumbiaEvaluating Implementation and Impact of Provincial Scale-up of the Adapted Choose to Move (CTM) Program | 2027-04 |
| NCT06345937University of TorontoMultiple Risk Factor Intervention Trial (Ms. FIT) | 2027-08-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 73 studies in Sedentary Behavior with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Canadians spend most of their day in sedentary postures (i.e., sitting, lying, reclining). While the beneficial impacts of physical activity on the heart are well-established, less is known about the consequences during time spent in sedentary postures. Currently, we know that spending time in a bout of uninterrupted sitting disrupts blood pressure regulation. However, it is unknown if there are any 'carry over' effects following uninterrupted sitting bouts (i.e., over the next 24-hours). The release of chemicals from arteries controls how stiff or relaxed they are and is important for controlling blood pressure. This is especially true for arteries directly impacted by sitting (e.g., the popliteal artery behind the knee) and that send blood to the brain (e.g., the carotid artery). We have also established that endothelial-derived hyperpolarizing factors (EDHF, chemicals that relax the artery) are important for the relaxation of the artery the popliteal artery. However, we do not know if the effects of EDHFs on this artery are decreased during or after a bout of uninterrupted sitting. A bout of prolonged sitting also causes blood pressure and fluctuations in blood pressure to increase. Importantly, we reported that fluctuations in blood pressure caused by sitting are higher in young males versus females, but average blood pressure was higher among females. These findings suggest that sitting exerts sex differences in the control of blood pressure. Importantly, these effects were only demonstrated during the 2-hour bout of sitting. As such, it is unknown whether blood pressure is negatively impacted after prolonged sitting. The proposed study will determine the impact of EDHFs on blood pressure regulation following a 2-hour bout of prolonged sitting among a group of healthy males and females. Continuous heart rate (via electrocardiogram) and blood pressure (via finger cuff), as well as blood flow from the common carotid artery (in the neck), middle cerebral artery (in the brain) and popliteal artery (behind the knee) will be measured before and after sitting (via ultrasound). The ability of the popliteal artery to relax will be assessed using ultrasound following the release of a pressure cuff. Finally, 24-hour blood pressure and heart rate will be recorded after sitting using a monitor worn for 24-hours. The role of EDHFs will be investigated by comparing 1) baseline blood flow and blood pressure responses (no sitting), 2) blood pressure responses following a 2-hour bout of sitting, and 3) the blood pressure responses following a 2-hour bout of sitting while suppressing the release of EDHFs (via fluconazole ingestion).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
o Younger than 18 years old. Individuals younger than 18 demonstrate more variable peak FMD responses and require multiple assessments to determine peak response.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Placebo · Drug: Fluconazole 150 mg
Drug: Placebo · Drug: Fluconazole 150 mg
Participants will take a placebo sugar pill before and after a bout of prolonged sitting as a control session.
Participants will take 150mg of fluconazole, an EDHF inhibitor before and after a bout of prolonged sitting.
Popliteal Low-Flow Mediated Constriction
During a period of distal cuff-induced ischemia, the endothelial-dependent vasoconstrictor response will be assessed via Duplex ultrasonography. The popliteal artery will be imaged slightly above the popliteal fossa. The L-FMC response will be quantified as the percent reduction in arterial diameter from baseline to the nadir diameter from the last 30-s of a 5-min distal cuff occlusion period.
Time frame: Before prolonged sitting, after 1-hour of sitting, after 2-hours of sitting
Acute Blood Pressure
Beat-by-beat systolic (SBP) and diastolic (DBP) blood pressure will be measured using finger photoplethysmography for 20 minutes before the bout of prolonged sitting, 20 minutes after 1-hour of sitting, and 20 minutes after 2-hours of sitting. Mean arterial pressure will be quantified as 1/3 SBP + 2/3 DBP.
Time frame: Before prolonged sitting, after 1-hour of sitting, after 2-hours of sitting.
Ambulatory Blood Pressure
Using an ABPMpro Ambulatory Blood Pressure Monitors, habitual blood pressure will be measured every 20-minutes during waking hours, and every 30-minutes during sleeping hours.
Time frame: This will be worn for a 24-hour period before the first prolonged sitting session, and for 24-hours after each bout of prolonged sitting.
Carotid Artery Blood Flow Velocity
Blood flow velocity will be measured immediately prior to the bifurcation in the common carotid artery using Duplex ultrasonography for 5 minutes.
Time frame: Before prolonged sitting, after 1-hour of sitting, after 2-hours of sitting.
Middle Cerebral Artery Velocity
Blood flow velocity will be measured via transcranial Doppler over the trans-temporal window for 5 minutes.
Time frame: Before prolonged sitting, after 1-hour of sitting, after 2-hours of sitting.
Popliteal Flow Mediated Dilation (FMD)
Following a period of distal cuff induced ischemia, the endothelial-dependent vasodilator response will be assessed via Duplex ultrasonography. The popliteal artery will be imaged slightly above the popliteal fossa. The FMD response will be quantified as the percent increase in arterial diameter from baseline to the peak diameter following the release of the distal cuff.
Time frame: Before prolonged sitting, after 1-hour of sitting, after 2-hours of sitting.
Physical Activity Behaviour Questionnaire
A subjective questionnaire that provides information regarding habitual physical activity and sedentary behaviours.
Time frame: At time of study enrolment
Heart Rate Variability (HRV)
Heart rate will be determined using cardiac intervals from a lead II electrocardiography during prolonged sitting, and from the built-in electrocardiogram in the ambulatory blood pressure monitor. HRV will be derived from these waveforms using an offline HRV analysis module. Time-domain (I.e., RMSSD), frequency-domain, low frequency (LF) power, high frequency (HF) power, and the LF/HF ratio will be quantified for each participant.
Time frame: Acute: Before prolonged sitting, after 1-hour of sitting, after 2-hours of sitting. Ambulatory: 24-hours at baseline, 24-hours after each bout of prolonged sitting.
Carotid Intima Media Thickness (cIMT)
cIMT will be determined from a 5-minute recording of the carotid artery, imaged prior to the bifurcation using Duplex ultrasonography.
Time frame: Before prolonged sitting, after 1-hour of sitting, after 2-hours of sitting.
Carotid Artery Distensibility
Distensibility will be determined from 5-minutes of recorded carotid artery imaging via Duplex ultrasonography, and will be calculated as the difference between average arterial diameter during systole and diastole.
Time frame: Before prolonged sitting, after 1-hour of sitting, after 2-hours of sitting.
Blood Pressure Varibility (BPV)
Beat-by-beat BPV during sitting will be quantified using the blood pressure measurements derived from finger photoplethysmography. This will be calculated as the average absolute difference between successive finger blood pressure measurements, for systolic blood pressure, diastolic blood pressure, and mean arterial pressure. Ambulatory BPV will be quantified from the 24-hour blood pressure monitors.
Time frame: Acute: Before prolonged sitting, after 1-hour of sitting, after 2-hours of sitting. Ambulatory: 24-hours at baseline, 24-hours after each bout of prolonged sitting.
Cardiovagal Baroreflex Sensitivity (cvBRS)
cvBRS will be quantified from beat-by-beat systolic blood pressure (SBP) and R-R intervals in a cvBRS software. cvBRS outcomes will be quantified from a minimum of 3 sequences in which beat-by-beat SBP changes were ≥1 mmHg and changes in R-R interval were ≥ 1 ms. Overall cvBRS is represented by the average slope of SBP and R-R interval regressions for the pooled sequences, and reported separately for both up and down sequences. Baroreflex effectiveness index (BEI) will be measured as the ratio of the number of SBP ramp-induced changes in RR interval to the total number of SBP ramps observed. This will be reported separately for both up and down sequences. This will be measured over a 20-minute time period.
Time frame: Before prolonged sitting, after 1 hour of sitting, after 2-hours of sitting.
Habitual Activity
Habitual activity will be measured using activPAL inclinometer-accelerometers positioned on the torso, thigh, and calf. Monitors will be waterproofed and attached 24-hr/day for 8 days via clear medical adhesive. Physical activity will be determined via validated, custom software that was developed and openly published by our group.
Time frame: Before first bout of sitting, after each bout of sitting.
Habitual Postures
Habitual postures will be measured using activPAL inclinometer-accelerometers positioned on the torso, thigh, and calf. Monitors will be waterproofed and attached 24-hr/day for 8 days via clear medical adhesive. Time spent in postures (e.g., sitting versus lying time) will be determined via validated, custom software that was developed and openly published by our group.
Time frame: Before first bout of sitting, after each bout of sitting.
Baseline Arterial Diameters
Arterial diameter of the popliteal and carotid arteries will be determined via Duplex ultrasonography over a minimum of 2-minutes.
Time frame: Before prolonged sitting, after 1-hour of sitting, after 2-hours of sitting.
Plan to share: No — IPD will not be shared to maintain privacy and confidentiality of the participants.
Started Nov 2025 (actual). Primary completion is estimated for Dec 2026, 13 months after the start.
Of 736 non-industry interventional studies with no phase under Sedentary Behavior, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 30. This study's planned 13 months is close to that.
Counting every sponsor, half of 744 studies reached it within 14 months; a quarter within 6 and three quarters within 30.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Fluconazole